Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Marinari

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
The Journal of Biological Chemistry|January 13, 2006
Herpes simplex virus disrupts NF-kappaB regulation by blocking its recruitment on the IkappaBalpha promoter and directing the factor on viral genesCarla Amici, Antonio Rossi, Antonio Costanzo, et al.
Drug Development Research|November 11, 2014
Detection of adalimumab and anti-adalimumab levels by ELISA: clinical considerationsBarbara Marinari, Elisabetta Botti, Mauro Bavetta, et al.
European Journal of Immunology|January 29, 2002
Vav cooperates with CD28 to induce NF-kappaB activation via a pathway involving Rac-1 and mitogen-activated kinase kinase 1Barbara Marinari, Antonio Costanzo, Antonella Viola, et al.
Oncogene|July 12, 2005
A p38-dependent pathway regulates DeltaNp63 DNA binding to p53-dependent promoters in UV-induced apoptosis of keratinocytesMarina Papoutsaki, Francesca Moretti, Mauro Lanza, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 2003
Vav-1 and the IKK alpha subunit of I kappa B kinase functionally associate to induce NF-kappa B activation in response to CD28 engagementEnza Piccolella, Francesca Spadaro, Carlo Ramoni, et al.
The Journal of International Medical Research|September 30, 2016
Long-term treatment with adalimumab in psoriatic arthritis: serum adalimumab concentration, immunogenicity and the link with clinical responseMaria Sole Chimenti, Paola Triggianese, Alessandra Narcisi, et al.
Plos One|July 24, 2008
Claudin-1 is a p63 target gene with a crucial role in epithelial developmentTeresa Lopardo, Nadia Lo Iacono, Barbara Marinari, et al.
The Journal of Investigative Dermatology|July 18, 2008
IKKalpha is a p63 transcriptional target involved in the pathogenesis of ectodermal dysplasiasBarbara Marinari, Costanza Ballaro, Maranke I Koster, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 30, 2008
The tumor suppressor activity of IKKalpha in stratified epithelia is exerted in part via the TGF-beta antiproliferative pathwayBarbara Marinari, Francesca Moretti, Elisabetta Botti, et al.
The Journal of Clinical Investigation|April 29, 2010
A regulatory feedback loop involving p63 and IRF6 links the pathogenesis of 2 genetically different human ectodermal dysplasiasFrancesca Moretti, Barbara Marinari, Nadia Lo Iacono, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
The Journal of Biological Chemistry|January 13, 2006
Herpes simplex virus disrupts NF-kappaB regulation by blocking its recruitment on the IkappaBalpha promoter and directing the factor on viral genesCarla Amici, Antonio Rossi, Antonio Costanzo, et al.
Drug Development Research|November 11, 2014
Detection of adalimumab and anti-adalimumab levels by ELISA: clinical considerationsBarbara Marinari, Elisabetta Botti, Mauro Bavetta, et al.
European Journal of Immunology|January 29, 2002
Vav cooperates with CD28 to induce NF-kappaB activation via a pathway involving Rac-1 and mitogen-activated kinase kinase 1Barbara Marinari, Antonio Costanzo, Antonella Viola, et al.
Oncogene|July 12, 2005
A p38-dependent pathway regulates DeltaNp63 DNA binding to p53-dependent promoters in UV-induced apoptosis of keratinocytesMarina Papoutsaki, Francesca Moretti, Mauro Lanza, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 2003
Vav-1 and the IKK alpha subunit of I kappa B kinase functionally associate to induce NF-kappa B activation in response to CD28 engagementEnza Piccolella, Francesca Spadaro, Carlo Ramoni, et al.
The Journal of International Medical Research|September 30, 2016
Long-term treatment with adalimumab in psoriatic arthritis: serum adalimumab concentration, immunogenicity and the link with clinical responseMaria Sole Chimenti, Paola Triggianese, Alessandra Narcisi, et al.
Plos One|July 24, 2008
Claudin-1 is a p63 target gene with a crucial role in epithelial developmentTeresa Lopardo, Nadia Lo Iacono, Barbara Marinari, et al.
The Journal of Investigative Dermatology|July 18, 2008
IKKalpha is a p63 transcriptional target involved in the pathogenesis of ectodermal dysplasiasBarbara Marinari, Costanza Ballaro, Maranke I Koster, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 30, 2008
The tumor suppressor activity of IKKalpha in stratified epithelia is exerted in part via the TGF-beta antiproliferative pathwayBarbara Marinari, Francesca Moretti, Elisabetta Botti, et al.
The Journal of Clinical Investigation|April 29, 2010
A regulatory feedback loop involving p63 and IRF6 links the pathogenesis of 2 genetically different human ectodermal dysplasiasFrancesca Moretti, Barbara Marinari, Nadia Lo Iacono, et al.
Pageof 3